Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation

Clinical trial NCT00383994 · COMPLETED

Trial details

NCT number: NCT00383994
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Leukemia Transplantation, Stem Cell Lymphoid Malignancies Disorder Related to Transplantation

Start date: 2006-09-01
Primary completion: 2019-07-22
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.